주식/증권
📈 긍정적
BioStem Technologies Q2 Earnings Call Highlights
요약
BioStem Technologies (OTCMKTS:BSEM) reported second-quarter revenue of $7.9 million as the company continued its transition to a predominantly hospital-focused commercial model. Revenue increased from $6.1 million in the first quarter, supported by higher hospital sales, expanded commercial coverage